The answer, as released on 11 September, was "To soon commence." Guess it can't come too soon for all of us investors.
So when is 'soon'? Must be soon.
To refresh, the ann stated that we had then received approval from the UK Medicines Regulatory Agency for Phase 1/2 trials against advanced melanoma, prostate, lung and bladder cancer.
Looking forward to some news of the commencement, sooner than 'soon.'
VLA Price at posting:
34.7¢ Sentiment: LT Buy Disclosure: Held
